Impairments	9 Months Ended
Sep. 30, 2024
Impairments [Abstract]
Impairments	25. Impairments During the three and nine months ending September, 30, 2023, the Company recognized an impairment of $2,391 and $7,291, respectively, on its investment in Securrency, Inc. to reduce the carrying value of its investment to fair value. During the three and nine months ended September 30, 2023, the Company recognized an impairment of $312 on its other investments.

The entire disclosure for the details of the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value. Disclosure may also include a description of the impaired asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired asset is reported.

No definition available.

Name:	us-gaap_AssetImpairmentChargesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration